스마트 의료기기 시장 : 제품 유형별, 용도별, 유통 채널별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global smart medical devices market was valued at $31,448.8 million in 2021, and is projected to reach $132,133.42 million by 2031, registering a CAGR of 15.4% from 2022 to 2031.

Recently evolved smart medical device technologies have helped to prevent & diagnose chronical diseases and provide real-time monitoring. Database records and servers play a vital role to maintain medical records, and provide facilities to the patients in need of hour. It describes the internet of things integrated advanced technologies useful in domain of healthcare. Early diagnosis might prevent severe illness & saves patients from untimely death. So, early diagnosis might save patients life. In current times, the internet of things based health applications focus on medical treatments of the diseases and monitoring the health of the patients via analyzing various parameters using smart devices. The healthcare system is slowly switching to remote healthcare by providing E-health services at homes. There are many applications existing for patient monitoring. In addition, various networks such as Wireless Body Area Network (WBAN), Wireless Local Area Network (WLAN), Radio-frequency Identification (RFID) and Wireless Personal Area Network (WPAN) assist in automatic identification and data capturing.

The global smart medical devices market is anticipated to show significant market growth during the forecast period, owing to surge in demand of smart medical devices, increase in prevalence of chronic diseases and increase in geriatric population. Furthermore, increase in healthcare expenditure, rise in incidence of diabetes, the rapidly evolving information and software technology and rise in healthcare expenditure are considerably contributing toward the market growth. However, stringent government regulations for medical devices and high cost of smart medical devices are negatively impacting the market growth. Conversely, the technological advancements in medical devices offers lucrative opportunities for the growth of the market.

The global smart medical devices market is segmented on the basis of product type, application, distribution channel and region. By on product type, the market is classified into diagnostic & monitoring devices and therapeutic devices. Furthermore, the diagnostic and monitoring devices segment is sub-classified as wearable and non-wearable. By application, the market is classified into blood glucose monitoring, cardiovascular and others. By distribution channel, the market is classified into pharmacies and online channel. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The major companies profiled in the report include Abbott Laboratories, Alphabet Inc. (Fitbit Inc.), Apple Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Dexcom Inc, Medtronic plc, Novo Nordisk A/S, Omron Corporation, Sonova, VitalConnect Inc., and West Pharmaceutical Services, Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart medical devices market analysis from 2021 to 2031 to identify the prevailing smart medical devices market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the smart medical devices market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global smart medical devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Distribution Channel

• Pharmacies
• Online Channel

By Product Type

• Diagnostic and Monitoring Devices
  • Modality
  • Wearable
  • Non-Wearable
• Therapeutic Devices

By Application

• Blood glucose monitoring
• Cardiovascular
• Othres

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA
• Key Market Players
  • Abbott Laboratories
  • Apple Inc.
  • biotronik
  • Boston Scientific Corporation
  • DexCom, Inc.
  • Fitbit, Inc.
  • Medtronic, Inc.
  • Novo Nordisk
  • Omron Corporation (Omron Healthcare)
  • Sonova
  • VitalConnect Inc
  • West Pharmaceutical Services, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SMART MEDICAL DEVICES MARKET, BY PRODUCT TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Diagnostic and Monitoring Devices
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
  • 4.2.4 Diagnostic and Monitoring Devices Smart Medical Devices Market by Modality
    • 4.2.4.1 Wearable Market size and forecast, by region
    • 4.2.4.2 Non-Wearable Market size and forecast, by region
• 4.3 Therapeutic Devices
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country

CHAPTER 5: SMART MEDICAL DEVICES MARKET, BY APPLICATION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Blood glucose monitoring
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Cardiovascular
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country
• 5.4 Othres
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market analysis by country

CHAPTER 6: SMART MEDICAL DEVICES MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Pharmacies
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Online Channel
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country

CHAPTER 7: SMART MEDICAL DEVICES MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.2.1 North America Diagnostic and Monitoring Devices Smart Medical Devices Market by Modality
  • 7.2.3 North America Market size and forecast, by Application
  • 7.2.4 North America Market size and forecast, by Distribution Channel
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Market size and forecast, by Product Type
    • 7.2.5.1.2 Market size and forecast, by Application
    • 7.2.5.1.3 Market size and forecast, by Distribution Channel
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Market size and forecast, by Product Type
    • 7.2.5.2.2 Market size and forecast, by Application
    • 7.2.5.2.3 Market size and forecast, by Distribution Channel
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Market size and forecast, by Product Type
    • 7.2.5.3.2 Market size and forecast, by Application
    • 7.2.5.3.3 Market size and forecast, by Distribution Channel
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.2.1 Europe Diagnostic and Monitoring Devices Smart Medical Devices Market by Modality
  • 7.3.3 Europe Market size and forecast, by Application
  • 7.3.4 Europe Market size and forecast, by Distribution Channel
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Market size and forecast, by Product Type
    • 7.3.5.1.2 Market size and forecast, by Application
    • 7.3.5.1.3 Market size and forecast, by Distribution Channel
    • 7.3.5.2 France
    • 7.3.5.2.1 Market size and forecast, by Product Type
    • 7.3.5.2.2 Market size and forecast, by Application
    • 7.3.5.2.3 Market size and forecast, by Distribution Channel
    • 7.3.5.3 UK
    • 7.3.5.3.1 Market size and forecast, by Product Type
    • 7.3.5.3.2 Market size and forecast, by Application
    • 7.3.5.3.3 Market size and forecast, by Distribution Channel
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Market size and forecast, by Product Type
    • 7.3.5.4.2 Market size and forecast, by Application
    • 7.3.5.4.3 Market size and forecast, by Distribution Channel
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Market size and forecast, by Product Type
    • 7.3.5.5.2 Market size and forecast, by Application
    • 7.3.5.5.3 Market size and forecast, by Distribution Channel
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Market size and forecast, by Product Type
    • 7.3.5.6.2 Market size and forecast, by Application
    • 7.3.5.6.3 Market size and forecast, by Distribution Channel
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.2.1 Asia-Pacific Diagnostic and Monitoring Devices Smart Medical Devices Market by Modality
  • 7.4.3 Asia-Pacific Market size and forecast, by Application
  • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 Japan
    • 7.4.5.1.1 Market size and forecast, by Product Type
    • 7.4.5.1.2 Market size and forecast, by Application
    • 7.4.5.1.3 Market size and forecast, by Distribution Channel
    • 7.4.5.2 China
    • 7.4.5.2.1 Market size and forecast, by Product Type
    • 7.4.5.2.2 Market size and forecast, by Application
    • 7.4.5.2.3 Market size and forecast, by Distribution Channel
    • 7.4.5.3 Australia
    • 7.4.5.3.1 Market size and forecast, by Product Type
    • 7.4.5.3.2 Market size and forecast, by Application
    • 7.4.5.3.3 Market size and forecast, by Distribution Channel
    • 7.4.5.4 India
    • 7.4.5.4.1 Market size and forecast, by Product Type
    • 7.4.5.4.2 Market size and forecast, by Application
    • 7.4.5.4.3 Market size and forecast, by Distribution Channel
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Market size and forecast, by Product Type
    • 7.4.5.5.2 Market size and forecast, by Application
    • 7.4.5.5.3 Market size and forecast, by Distribution Channel
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Market size and forecast, by Product Type
    • 7.4.5.6.2 Market size and forecast, by Application
    • 7.4.5.6.3 Market size and forecast, by Distribution Channel
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.2.1 LAMEA Diagnostic and Monitoring Devices Smart Medical Devices Market by Modality
  • 7.5.3 LAMEA Market size and forecast, by Application
  • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Market size and forecast, by Product Type
    • 7.5.5.1.2 Market size and forecast, by Application
    • 7.5.5.1.3 Market size and forecast, by Distribution Channel
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Market size and forecast, by Product Type
    • 7.5.5.2.2 Market size and forecast, by Application
    • 7.5.5.2.3 Market size and forecast, by Distribution Channel
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Market size and forecast, by Product Type
    • 7.5.5.3.2 Market size and forecast, by Application
    • 7.5.5.3.3 Market size and forecast, by Distribution Channel
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Market size and forecast, by Product Type
    • 7.5.5.4.2 Market size and forecast, by Application
    • 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Abbott Laboratories
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 Apple Inc.
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 biotronik
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 Boston Scientific Corporation
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 DexCom, Inc.
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Fitbit, Inc.
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Medtronic, Inc.
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Novo Nordisk
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Omron Corporation (Omron Healthcare)
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Sonova
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments
• 9.11 VitalConnect Inc
  • 9.11.1 Company overview
  • 9.11.2 Company snapshot
  • 9.11.3 Operating business segments
  • 9.11.4 Product portfolio
  • 9.11.5 Business performance
  • 9.11.6 Key strategic moves and developments
• 9.12 West Pharmaceutical Services, Inc.
  • 9.12.1 Company overview
  • 9.12.2 Company snapshot
  • 9.12.3 Operating business segments
  • 9.12.4 Product portfolio
  • 9.12.5 Business performance
  • 9.12.6 Key strategic moves and developments